SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin

Free Radical Biology and Medicine

Volumn 46, Issue 6, 2009, Pages 836-841

  Zillikens, M Carola ^a   van Meurs, Joyce B J ^a   Sijbrands, Eric J G ^a   Rivadeneira, Fernando ^a   Dehghan, Abbas ^a   van Leeuwen, Johannes P T M ^a   Hofman, Albert ^a   van Duijn, Cornelia M ^a   Witteman, Jacqueline C M ^a   Uitterlinden, André G ^a   Pols, Huibert A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

B vitamins; Free radicals; Genetic association; Mortality; Niacin; Oxidative stress; SIRT1; Smoking; Type 2 diabetes

Indexed keywords

NICOTINIC ACID; SIRTUIN 1;

ADULT; AGED; ARTICLE; DIABETIC PATIENT; DIETARY INTAKE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NICOTINIC ACID DEFICIENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SIRT1 GENE; SMOKING;

AGED; AGING; COHORT STUDIES; CYTOPROTECTION; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NIACIN; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIRTUIN 1; SMOKING; SURVIVAL ANALYSIS;

EID: 60449118870     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.12.022     Document Type: Article

References (47)

1. Sinclair D.A., and Guarente L. Extrachromosomal rDNA circles-a cause of aging in yeast. Cell 91 (1997) 1033-1042
2. Blander G., and Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73 (2004) 417-435
3. Lin S.J., Defossez P.A., and Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289 (2000) 2126-2128
4. Rogina B., and Helfand S.L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 101 (2004) 15998-16003
5. Wang Y., and Tissenbaum H.A. Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO. Mech. Ageing Dev. 127 (2006) 48-56
6. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
7. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., and Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107 (2001) 137-148
8. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., and Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
9. Araki T., Sasaki Y., and Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305 (2004) 1010-1013
10. Alcendor R.R., Kirshenbaum L.A., Imai S., Vatner S.F., and Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 95 (2004) 971-980
11. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., and Neri C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37 (2005) 349-350
12. + depletion and reduced Sir2alpha deacetylase activity. J. Biol. Chem. 280 (2005) 43121-43130
13. Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isono M., Isshiki K., Uzu T., Kashiwagi A., and Koya D. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radic. Biol. Med. 40 (2006) 2175-2182
14. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M.W., and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 (2004) 771-776
15. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., and Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434 (2005) 113-118
16. Frescas D., Valenti L., and Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280 (2005) 20589-20595
17. Moynihan K.A., Grimm A.A., Plueger M.M., Bernal-Mizrachi E., Ford E., Cras-Meneur C., Permutt M.A., and Imai S. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2 (2005) 105-117
18. Bordone L., Motta M.C., Picard F., Robinson A., Jhala U.S., Apfeld J., McDonagh T., Lemieux M., McBurney M., Szilvasi A., Easlon E.J., Lin S.J., and Guarente L. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4 (2006) e31
19. Sauve A.A., and Schramm V.L. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 42 (2003) 9249-9256
20. Revollo J.R., Grimm A.A., and Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279 (2004) 50754-50763
21. Aksoy P., Escande C., White T.A., Thompson M., Soares S., Benech J.C., and Chini E.N. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem. Biophys. Res. Commun. 349 (2006) 353-359
22. van der Veer E., Ho C., O'Neil C., Barbosa N., Scott R., Cregan S.P., and Pickering J.G. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 282 (2007) 10841-10845
23. Flachsbart F., Croucher P.J., Nikolaus S., Hampe J., Cordes C., Schreiber S., and Nebel A. Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. Exp. Gerontol. 41 (2006) 98-102
24. Kuningas M., Putters M., Westendorp R.G., Slagboom P.E., and van Heemst D. SIRT1 gene, age-related diseases, and mortality: the Leiden 85-Plus Study. J. Gerontol. A Biol. Sci. Med. Sci. 62 (2007) 960-965
25. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., and Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
26. Zhang J. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?. Bioessays 25 (2003) 808-814
27. Szabo C. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res. 52 (2005) 60-71
28. Kolthur-Seetharam U., Dantzer F., McBurney M.W., de Murcia G., and Sassone-Corsi P. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle (Georgetown) 5 (2006) 873-877
29. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid. Redox Signaling 9 (2007) 931-942
30. Balestrieri M.L., Rienzo M., Felice F., Rossiello R., Grimaldi V., Milone L., Casamassimi A., Servillo L., Farzati B., Giovane A., and Napoli C. High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim. Biophys. Acta 1784 (2008) 936-945
31. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., and Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. 292 (2007) L567-576
32. Rajendrasozhan S., Yang S.R., Kinnula V.L., and Rahman I. SIRT1, an anti-inflammatory and anti-aging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177 (2008) 861-870
33. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7 (1991) 403-422
34. Hofman A., Breteler M.M., van Duijn C.M., Krestin G.P., Pols H.A., Stricker B.H., Tiemeier H., Uitterlinden A.G., Vingerling J.R., and Witteman J.C. The Rotterdam Study: objectives and design update. Eur. J. Epidemiol. 22 (2007) 819-829
35. Sayed-Tabatabaei F.A., Schut A.F., Vasquez A.A., Bertoli-Avella A.M., Hofman A., Witteman J.C., and van Duijn C.M. Angiotensin converting enzyme gene polymorphism and cardiovascular morbidity and mortality: the Rotterdam Study. J. Med. Genet. 42 (2005) 26-30
36. Klipstein-Grobusch K., den Breeijen J.H., Goldbohm R.A., Geleijnse J.M., Hofman A., Grobbee D.E., and Witteman J.C. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur. J. Clin. Nutr. 52 (1998) 588-596
37. Willett W.C., Howe G.R., and Kushi L.H. Adjustment for total energy intake in epidemiologic studies. Am. J. Clin. Nutr. 65 (1997) 1220S-1228S discussion 1229S-1231S
38. van Gent C.M., van der Voort H.A., de Bruyn A.M., and Klein F. Cholesterol determinations: a comparative study of methods with special reference to enzymatic procedures. Clin. Chim. Acta 75 (1977) 243-251
39. Raymond M., and Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J. Hered. 86 (1995) 248-249
40. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
41. Rogus J.J., Warram J.H., and Krolewski A.S. Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 51 (2002) 1655-1662
42. Geissler C., and Powers H. Human Nutrition. 11th ed. (2005), Elsevier, Amsterdam
43. Jungjohann S.M., Luhrmann P.M., Bender R., Blettner M., and Neuhauser-Berthold M. Eight-year trends in food, energy and macronutrient intake in a sample of elderly German subjects. Br. J. Nutr. 93 (2005) 361-378
44. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
45. Csiszar A., Labinskyy N., Podlutsky A., Kaminski P.M., Wolin M.S., Zhang C., Mukhopadhyay P., Pacher P., Hu F., de Cabo R., Ballabh P., and Ungvari Z. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H2721-2735
46. de la Lastra C.A., and Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49 (2005) 405-430
47. Milne J.C., Lambert P.D., Schenk S., Carney D.P., Smith J.J., Gagne D.J., Jin L., Boss O., Perni R.B., Vu C.B., Bemis J.E., Xie R., Disch J.S., Ng P.Y., Nunes J.J., Lynch A.V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D.A., Olefsky J.M., Jirousek M.R., Elliott P.J., and Westphal C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450 (2007) 712-716